Condition
Locally Advanced Pancreatic Ductal Adenocarcinoma clinical trials and research
Research outlook What's coming for Pancreatic cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 9 Locally Advanced Pancreatic Ductal Adenocarcinoma clinical trials that are recruiting, at sites in 4 countries (most in United States (6), Canada (1), South Korea (1)). By phase: Early Phase 1 (2), Phase 1/2 (2), Phase 2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 4Countries
Newest Locally Advanced Pancreatic Ductal Adenocarcinoma clinical trials
All recruiting trials (9)
-
Samuraciclib given before surgery or chemotherapy for certain pancreatic cancers
This study tests whether taking samuraciclib before standard treatment is safe and helps patients with localized pancreatic cancer.
-
PULSAR personalized ultrafractionated adaptive proton radiotherapy combined with systemic therapy for pancreatic cancer
This trial will test whether personalized PULSAR proton radiotherapy given after initial chemotherapy can improve local control for people with borderline resectable, locally advanced, or limited metastatic pancreatic cancer.
-
XER-001 (nasoduodenal amifostine) with SBRT for locally advanced pancreatic cancer
This trial tests whether giving XER-001 through a nasoduodenal tube together with stereotactic body radiotherapy (SBRT) is safe and helpful for people with locally advanced pancreatic cancer.
-
GnP plus serplulimab with stereotactic body radiation therapy for first-line locally advanced pancreatic cancer.
This trial will test whether combining GnP chemotherapy, the immunotherapy serplulimab, and focused SBRT helps people aged 18–75 with untreated, locally advanced pancreatic ductal adenocarcinoma.
-
OMO-103 for advanced or metastatic pancreatic ductal adenocarcinoma
This trial tests an experimental IV drug called OMO-103 to see if it changes tumor cells in adults with locally advanced or metastatic pancreatic ductal adenocarcinoma.
-
Using advanced MRI to assess treatment response in pancreatic cancer
This study is testing a new MRI technique to see if it can better predict how well treatment works for people with pancreatic cancer.
-
Tumor DNA and protein testing to understand pancreatic cancer treatment response
This trial will test whether measuring tumor DNA and proteins from people with resectable or locally advanced pancreatic ductal adenocarcinoma can be done quickly enough and provide information about how their cancer responds to standard chemotherapy.
-
Combining zimberelimab and quemliclustat with chemotherapy for advanced pancreatic cancer
This study is testing if a new combination of zimberelimab and quemliclustat with chemotherapy can help people with advanced pancreatic cancer live longer and have better treatment outcomes.
-
Targeted therapy for pancreatic cancer using new drugs
This study is testing new targeted therapies for pancreatic cancer to see how well they work and if they are safe for patients at different stages of the disease.
Related topics
Quick answers
How many Locally Advanced Pancreatic Ductal Adenocarcinoma clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (6 trials), Canada (1 trial), South Korea (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 2, Phase 1/2: 2, Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.